Found: 16
Select item for more details and to access through your institution.
A Pilot Phase 2 Randomized Trial to Evaluate the Safety and Potential Efficacy of Etravirine in Friedreich Ataxia Patients.
- Published in:
- Children, 2024, v. 11, n. 8, p. 958, doi. 10.3390/children11080958
- By:
- Publication type:
- Article
Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
An RNA-seq study in Friedreich ataxia patients identified hsa-miR-148a-3p as a putative prognostic biomarker of the disease.
- Published in:
- Human Genomics, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s40246-024-00602-y
- By:
- Publication type:
- Article
Preventing the ubiquitin–proteasome-dependent degradation of frataxin, the protein defective in Friedreich's ataxia.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 7, p. 1253, doi. 10.1093/hmg/ddq566
- By:
- Publication type:
- Article
Molecular control of the cytosolic aconitase/IRP1 switch by extramitochondrial frataxin.
- Published in:
- Human Molecular Genetics, 2010, v. 19, n. 7, p. 1221, doi. 10.1093/hmg/ddp592
- By:
- Publication type:
- Article
In vivo maturation of human frataxin.
- Published in:
- Human Molecular Genetics, 2007, v. 16, n. 13, p. 1534, doi. 10.1093/hmg/ddm102
- By:
- Publication type:
- Article
Interferon Gamma Enhances Cytoprotective Pathways via Nrf2 and MnSOD Induction in Friedreich's Ataxia Cells.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 12687, doi. 10.3390/ijms241612687
- By:
- Publication type:
- Article
Biophysical characterisation of the recombinant human frataxin precursor.
- Published in:
- FEBS Open Bio, 2018, v. 8, n. 3, p. 390, doi. 10.1002/2211-5463.12376
- By:
- Publication type:
- Article
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo.
- Published in:
- Biology Direct, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13062-023-00374-w
- By:
- Publication type:
- Article
Drug Repositioning in Friedreich Ataxia.
- Published in:
- Frontiers in Neuroscience, 2022, v. 16, p. 1, doi. 10.3389/fnins.2022.814445
- By:
- Publication type:
- Article
Sensitivity of Neuroimaging Indicators in Monitoring the Effects of Interferon Gamma Treatment in Friedreich's Ataxia.
- Published in:
- Frontiers in Neuroscience, 2020, v. 14, p. N.PAG, doi. 10.3389/fnins.2020.00872
- By:
- Publication type:
- Article
Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression.
- Published in:
- EMBO Journal, 2006, v. 25, n. 9, p. 1895, doi. 10.1038/sj.emboj.7601085
- By:
- Publication type:
- Article
Safety and efficacy of interferon γ in friedreich's ataxia.
- Published in:
- 2020
- By:
- Publication type:
- letter
Hsa-miR223-3p circulating level is upregulated in Friedreich's ataxia and inversely associated with HCLS1 associated protein X-1, HAX-1.
- Published in:
- Human Molecular Genetics, 2022, v. 31, n. 12, p. 2010, doi. 10.1093/hmg/ddac005
- By:
- Publication type:
- Article
Frataxin deficiency in Friedreich's ataxia is associated with reduced levels of HAX-1, a regulator of cardiomyocyte death and survival.
- Published in:
- Human Molecular Genetics, 2020, v. 29, n. 3, p. 471, doi. 10.1093/hmg/ddz306
- By:
- Publication type:
- Article
Src inhibitors modulate frataxin protein levels.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 15, p. 4296, doi. 10.1093/hmg/ddv162
- By:
- Publication type:
- Article